BioXcel Therapeutics, Inc.

Ownership Transactions Reported by 31 Insiders

Symbol
BTAI on Nasdaq
Industry
Pharmaceutical Preparations
Location
555 Long Wharf Drive, New Haven, Connecticut

Insiders trading volume in the past year

BioXcel Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Rashmi Agarwal 10%+ Owner $22.4 M Apr 3, 2023
Vipin Agarwal 10%+ Owner $22.4 M Apr 3, 2023
Tarun K. Gupta 10%+ Owner $22.4 M Apr 3, 2023
Indu R. Gupta 10%+ Owner $22.4 M Apr 3, 2023
Suganthi Balasubramanian 10%+ Owner $22.4 M Apr 3, 2023
Diwakar Jain 10%+ Owner $22.4 M Apr 3, 2023
Anita Jain 10%+ Owner $22.4 M Apr 3, 2023
BioXcel LLC 10%+ Owner $22.4 M Jun 25, 2021
Akrati Agarwal 10%+ Owner $22.4 M Apr 3, 2023
Krishnan Nandabalan Director, 10%+ Owner $22.4 M Apr 6, 2023
Marshal D. Gibson 10%+ Owner $22.4 M Apr 3, 2023
Bina Patel 10%+ Owner $22.4 M Apr 3, 2023
Jatin Patel 10%+ Owner $22.4 M Apr 3, 2023
Alka Sood 10%+ Owner $22.4 M Apr 3, 2023
Pardeep Sood 10%+ Owner $22.4 M Apr 3, 2023
Anesha Agarwal 10%+ Owner $22.4 M Apr 3, 2023
Krunal Patel 10%+ Owner $22.4 M Apr 3, 2023
Michael James Aiello 10%+ Owner $22.4 M Apr 3, 2023
BioXcel Holdings, Inc. 10%+ Owner $22.4 M Jun 25, 2021
Vimal Mehta CEO and President, Director, 10%+ Owner $9.98 M -$422 K -4.06% Jun 14, 2024
Frank Yocca Chief Scientific Officer $25.1 K -$3.29 K -11.6% Jun 14, 2024
Javier Rodriguez Chief Legal Officer, Senior Vice President and Corporate Secretary $18.6 K -$3.12 K -14.4% Jun 14, 2024
Matthew T. Wiley Chief Commercial Officer $14.8 K -$2.96 K -16.7% Jun 15, 2024
Richard Steinhart Chief Financial Officer $14.7 K -$3.29 K -18.2% Jun 14, 2024
Vincent O'Neill Executive Vice President, Chief of Product Development and Medical Officer $9.21 K -$632 -6.42% Jun 14, 2024
Michael Patrick Miller Director Jun 10, 2024
Sandeep Laumas Director Jun 10, 2024
Peter Mueller Director Jun 10, 2024
Michal Votruba Director Jun 10, 2024
June Bray Director Jun 10, 2024
William P. Kane Jr Chief Commercial Officer Aug 16, 2021

Recent Insider Transactions by Companies or Individuals for BioXcel Therapeutics, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership